The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offisite pharmacy and delivered as a ready-to-use unit dose. The Food and Drug Administration (FDA) ...
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine ...
Based on the clinical and scientific evidence now available, there are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded.” — Timothy Bateman, ...
The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results